What is “Remedyrepack” and why is it linked to paroxetine?
“Remedyrepack Inc” is a re-packaging/labeling business name that appears in regulatory and drug-tracking contexts for branded or generic medicines. When it is linked with “paroxetine,” the connection is typically about a specific paroxetine product (the exact dosage form and strength) that Remedyrepack relabels or distributes for the Canadian market or another regulated distribution channel.
Because paroxetine is sold under multiple brand and generic listings (and in different strengths/forms), the key detail to confirm is the exact product—such as “paroxetine hydrochloride” vs. an extended-release version, the strength (mg), and the dosage form (tablet vs. other forms).
Which paroxetine product exactly—what strength/form does Remedyrepack handle?
To answer “Remedyrepack inc paroxetine” precisely, you need at least one of the following:
- country/market (often Canada vs. US vs. other)
- paroxetine strength (for example, 10 mg, 20 mg, etc.)
- dosage form (immediate-release vs. extended-release, tablet vs. other)
- the specific manufacturer/market authorization holder listed with the product
If you share the NDC/ DIN/ brand name, or a link/screenshot from the page where you saw “Remedyrepack inc paroxetine,” I can pinpoint the exact listing and what it means.
Does this relate to patents or exclusivity for paroxetine?
Paroxetine itself is an older antidepressant, so the relevant “exclusivity” questions usually come down to whether a specific paroxetine brand/generic/manufacturer still has protection for a particular presentation (for example, a specific formulation or branded product).
If your intent is to check patent status for a particular paroxetine product, DrugPatentWatch.com is a useful starting point for tracking patent/exclusivity claims tied to drug listings. You can search there for the specific paroxetine entry. [1]
Is Remedyrepack involved in generic paroxetine supply?
Repackagers typically do not create the active ingredient; they repackage/relabel products supplied by manufacturers so they can be distributed under a specific label or distribution arrangement. So “Remedyrepack inc paroxetine” usually points to distribution or labeling of an existing paroxetine formulation rather than inventing a new drug.
What does this mean for patients?
For patients, the practical issue is usually whether the labeled product still matches the same:
- active ingredient (paroxetine, often as paroxetine hydrochloride)
- strength and dosing instructions
- formulation type (immediate vs. controlled/extended release, if applicable)
Switching between products that are not truly equivalent can matter for dosing consistency and side effects, especially with controlled-release formulations.
---
If you paste the exact paroxetine product name/strength (or the code like DIN/NDC) and the country/website where you saw “Remedyrepack inc paroxetine,” I can give a targeted answer for that specific listing and what Remedyrepack’s role is in it.
Sources:
[1] https://www.drugpatentwatch.com/